Literature DB >> 33030353

Are long-term influenza vaccines possible and how do we discover them?

Joo Kyung Kim1, Sang-Moo Kang1, Richard W Compans2, Bao-Zhong Wang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33030353      PMCID： PMC7904565          DOI： 10.1080/17460441.2021.1828859

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN： 1746-0441            Impact factor:   6.098


× No keyword cloud information.
  14 in total

1.  Influenza vaccine--outmaneuvering antigenic shift and drift.

Authors:  John Treanor
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

2.  A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen.

Authors:  Antonietta Impagliazzo; Fin Milder; Harmjan Kuipers; Michelle V Wagner; Xueyong Zhu; Ryan M B Hoffman; Ruud van Meersbergen; Jeroen Huizingh; Patrick Wanningen; Johan Verspuij; Martijn de Man; Zhaoqing Ding; Adrian Apetri; Başak Kükrer; Eveline Sneekes-Vriese; Danuta Tomkiewicz; Nick S Laursen; Peter S Lee; Anna Zakrzewska; Liesbeth Dekking; Jeroen Tolboom; Lisanne Tettero; Sander van Meerten; Wenli Yu; Wouter Koudstaal; Jaap Goudsmit; Andrew B Ward; Wim Meijberg; Ian A Wilson; Katarina Radošević
Journal:  Science       Date:  2015-08-24       Impact factor: 47.728

Review 3.  Avian influenza pandemic: not if, but when.

Authors:  Pat Jackson Allen
Journal:  Pediatr Nurs       Date:  2006 Jan-Feb

Review 4.  The evolution of seasonal influenza viruses.

Authors:  Velislava N Petrova; Colin A Russell
Journal:  Nat Rev Microbiol       Date:  2017-10-30       Impact factor: 60.633

5.  A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.

Authors:  Emily J Erbelding; Diane J Post; Erik J Stemmy; Paul C Roberts; Alison Deckhut Augustine; Stacy Ferguson; Catharine I Paules; Barney S Graham; Anthony S Fauci
Journal:  J Infect Dis       Date:  2018-07-02       Impact factor: 5.226

6.  Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses.

Authors:  M Gordon Joyce; Adam K Wheatley; Paul V Thomas; Gwo-Yu Chuang; Cinque Soto; Robert T Bailer; Aliaksandr Druz; Ivelin S Georgiev; Rebecca A Gillespie; Masaru Kanekiyo; Wing-Pui Kong; Kwanyee Leung; Sandeep N Narpala; Madhu S Prabhakaran; Eun Sung Yang; Baoshan Zhang; Yi Zhang; Mangaiarkarasi Asokan; Jeffrey C Boyington; Tatsiana Bylund; Sam Darko; Christopher R Lees; Amy Ransier; Chen-Hsiang Shen; Lingshu Wang; James R Whittle; Xueling Wu; Hadi M Yassine; Celia Santos; Yumiko Matsuoka; Yaroslav Tsybovsky; Ulrich Baxa; James C Mullikin; Kanta Subbarao; Daniel C Douek; Barney S Graham; Richard A Koup; Julie E Ledgerwood; Mario Roederer; Lawrence Shapiro; Peter D Kwong; John R Mascola; Adrian B McDermott
Journal:  Cell       Date:  2016-07-21       Impact factor: 41.582

7.  Deaths associated with influenza pandemic of 1918-19, Japan.

Authors:  Siddharth Chandra
Journal:  Emerg Infect Dis       Date:  2013-04       Impact factor: 6.883

Review 8.  Universal influenza vaccines, a dream to be realized soon.

Authors:  Han Zhang; Li Wang; Richard W Compans; Bao-Zhong Wang
Journal:  Viruses       Date:  2014-04-29       Impact factor: 5.048

Review 9.  From Variation of Influenza Viral Proteins to Vaccine Development.

Authors:  Wandi Zhu; Chao Wang; Bao-Zhong Wang
Journal:  Int J Mol Sci       Date:  2017-07-18       Impact factor: 5.923

10.  Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.

Authors:  Norbert Pardi; Michael J Hogan; Martin S Naradikian; Kaela Parkhouse; Derek W Cain; Letitia Jones; M Anthony Moody; Hans P Verkerke; Arpita Myles; Elinor Willis; Celia C LaBranche; David C Montefiori; Jenna L Lobby; Kevin O Saunders; Hua-Xin Liao; Bette T Korber; Laura L Sutherland; Richard M Scearce; Peter T Hraber; István Tombácz; Hiromi Muramatsu; Houping Ni; Daniel A Balikov; Charles Li; Barbara L Mui; Ying K Tam; Florian Krammer; Katalin Karikó; Patricia Polacino; Laurence C Eisenlohr; Thomas D Madden; Michael J Hope; Mark G Lewis; Kelly K Lee; Shiu-Lok Hu; Scott E Hensley; Michael P Cancro; Barton F Haynes; Drew Weissman
Journal:  J Exp Med       Date:  2018-05-08       Impact factor: 17.579
View more
  1 in total

1.  Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats.

Authors:  Chunhong Dong; Bao-Zhong Wang
Journal:  Adv Nanobiomed Res       Date:  2021-12-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.